# Submission rejected

## DRAFT REJECTED

**SPAR verdict:** `reject_critical` (3-0 unanimous reject).

## Proposed thesis (rejected)

> This research is being done to determine if Metformin, an FDA-approved diabetes medication, is effective at enhancing immune responses to flu vaccine in older men and women.

## Panel reviews

### `evidence_auditor` — `reject` (score 2)

All four claims (C066, C067, C068, C069) are marked as 'direct' claims. According to the auditor guidelines, direct claims must be supported by a 'published_results' citation. However, the citation trace for reference [29] (NCT03996538) explicitly states 'has_results=False'. Therefore, these claims lack the required published evidence to support a 'direct' designation.

Additionally, there is a critical failure in the trace for C069. The alias match resolved 'Immune' to 'VACCINIA IMMUNE GLOBULIN', which is a specific medication and entirely unrelated to the claim regarding the evaluation of 'immune responses' in a flu vaccine study. This indicates a failure in the evidence trace logic.

**Flagged claims:** C066, C067, C068, C069

### `domain_skeptic` — `reject` (score 3)

The submission is fundamentally flawed because it presents a study protocol (the 'intent' of the research) as a set of claims, while failing to provide any actual results or conclusions. As a domain skeptic, I find the framing highly problematic: the thesis [C066] claims the research is being done to 'determine if' metformin is effective, but the submission offers no evidence of effectiveness, only a description of a trial design. 

Furthermore, there is a critical technical error in the citation traces. The alias match for [C069] resolves 'Immune' to 'VACCINIA IMMUNE GLOBULIN'. This is a massive off-topic drift; the study is about immune responses to a flu vaccine, not the administration of a specific vaccine-derived immunoglobulin product. This suggests a failure in the evidence mapping process, conflating a general biological response with a specific pharmaceutical agent.

**Flagged claims:** C066, C069

### `final_judge` — `reject` (score 2)

I align with both the Evidence Auditor and the Domain Skeptic. The submission fails on two primary fronts: evidentiary standards and technical accuracy. First, the claims are presented as 'direct' facts, yet they are supported solely by a clinical trial registration (NCT03996538) that has no published results. A study protocol describes intent, not evidence of effectiveness or outcome, making the 'direct' designation inappropriate for a research claim.

Second, the citation trace for C069 contains a critical hallucination/mapping error where the general term 'Immune responses' was resolved to 'VACCINIA IMMUNE GLOBULIN'. This is a categorical error that conflates a physiological measurement with a specific pharmaceutical product, rendering the trace for that claim invalid. Given the lack of results and the failure of the evidence mapping, the submission cannot be accepted.

**Flagged claims:** C066, C067, C068, C069

## References

[29] Vaccination Efficacy With Metformin in Older Adults (2020). https://clinicaltrials.gov/study/NCT03996538
